Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Biol Pharm Bull. 2009 Feb;32(2):172–178. doi: 10.1248/bpb.32.172

Table 1.

Hepatic 8OHdG, TBARS, hydroperoxide, bile acid and triglyceride concentrations, and plasma ALT activity in Fxr-null mice

Liver
Plasma
8OHdG

(ng/g liver)
TBARS

(nmol MDA/g liver)
Hydroperoxide

(µmol DCFein/g liver)
Bile acid

(µmol/g liver)
Triglyceride

(mg/g liver)
ALT

(IU/L)


Control 4.1 ± 0.5 103 ± 31 2.29 ± 0.42 0.58 ± 0.35 20.9 ± 6.4 108 ± 54
ME3738 2.7 ± 0.5# 58 ± 9# 1.60 ± 0.10# 0.20 ± 0.11# 17.0 ± 4.1 42 ± 23#
CA 6.8 ± 1.5## 295 ± 108# 3.73 ± 0.54## 2.92 ± 0.89## 19.1 ± 8.8 266 ±89##
CA+ME3738 4.1 ± 0.7** 172 ± 28* 2.52 ± 0.58** 1.35 ± 0.51** 13.2 ± 4.3 158 ± 52*

Liver homogenate was prepared from Fxr-null mice fed the control, and 0.15% ME3738, 0.25% CA, or CA+ME3738 diet for 6 days. Hepatic 8OHdG concentrations were measured by ELISA. Hepatic TBARS and bile acid concentrations, and plasma ALT activity were measured by enzyme-colorimetric method. Hepatic hydroperoxide concentrations were measured as fluorescence of dichlorofluorescein-diacetate. Data are shown as mean ± S.D. (control; n=8, others; n=4).

#, ##

significantly different from the control group (p<0.05, p<0.01, respectively),

*, **

significantly different from CA group (p<0.05, p<0.01, respectively)